View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

B.F. Holding S.p.A: 1 director

A director at B.F. Holding S.p.A bought 23,742 shares at 3.745EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

BICO Group AB: 1 director

A director at BICO Group AB bought 12,051 shares at 37.340SEK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc 09-May-2024 / 13:53 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the t...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: BHP Group Limited

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: BHP Group Limited 09-May-2024 / 13:51 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s)...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limit...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited 09-May-2024 / 13:54 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tru...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc 09-May-2024 / 13:52 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the tru...

 PRESS RELEASE

LPL Financial Welcomes Advisor Chris Kitaeff

LPL Financial Welcomes Advisor Chris Kitaeff SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- announced today that financial advisor Chris Kitaeff, CPFA, MBA, has joined LPL Financial’s broker-dealer, RIA and custodial platforms. With the move to LPL, Kitaeff joins as a managing director. He reported serving approximately $385 million in advisory, brokerage and retirement plan assets* and joins LPL from Merrill Lynch. Kitaeff is a second-generation advisor who fell in love with wealth management at a young age and followed his father’s footsteps into the industry. He started his career on W...

Next Biometrics Group ASA: 1 director

A director at Next Biometrics Group ASA sold after exercising options/bought 200,000 shares at 8.530NOK and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...

James Ratzer
  • James Ratzer

CityFibre & Three UK Can they get their deals done by year-end?

Perhaps two of the most significant questions facing the UK telecoms market this year are i) whether the Vodafone/ Three merger will go through, and ii) whether the altnets can be successful operationally and have access on ongoing funding.

 PRESS RELEASE

The ODP Corporation Renews and Extends Existing Asset-Based Credit Fac...

BOCA RATON, Fla.--(BUSINESS WIRE)-- The ODP Corporation (NASDAQ:ODP) (“ODP,” or the “Company”), a leading provider of business services, products and digital workplace technology solutions to businesses and consumers, today announced that it has amended and extended its existing asset-based credit facility. The amendment extends the maturity date to May 2029. The renewed $800 million facility includes certain more attractive credit terms and conditions, enhancing the company’s balance sheet and liquidity position to support future growth. “The extension of our credit facility is a validation...

 PRESS RELEASE

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May ...

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a to discuss the Company’s Q1 2024 operational and financial results on Thursday, May 16, 2024, at 8:30 AM ET. The call will be hosted by members of AIM’s leadership team, Thomas K. Equels, Chief Executive Officer and Christopher McAleer, PhD, Scientific Officer. Interested participants and investors may access the conference call by diali...

National Australia Bank Limited: 1 director

A director at National Australia Bank Limited bought 4,380 shares at 34.000AUD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

 PRESS RELEASE

GXO meldet Ergebnisse für das erste Quartal 2024

GXO meldet Ergebnisse für das erste Quartal 2024 Umsatz im ersten Quartal von 2,5 Mrd. USD, 6 % mehr als im Vorjahr; organisches Umsatzwachstum1 von 1 %Neue Geschäftsabschlüsse mit einem Jahresumsatz von ca. 250 Mio. USD im 1. Quartal 2024; Anstieg um 55 % im JahresvergleichVerkaufspipeline erreicht 12-Monats-Hoch von 2,2 Mrd. USDAbschluss der Übernahme von Wincanton am 29. April 2024 GREENWICH, Connecticut, May 09, 2024 (GLOBE NEWSWIRE) -- (NYSE: GXO) hat heute die Ergebnisse für das erste Quartal 2024 bekanntgegeben. Malcolm Wilson, Chief Executive Officer von GXO, dazu: „Wir...

 PRESS RELEASE

GXO publie ses résultats pour le premier trimestre 2024

GXO publie ses résultats pour le premier trimestre 2024 Chiffre d’affaires arrêté à 2,5 milliards de dollars, soit une hausse de 6 % par rapport à l’année précédente ; et croissance organique1 de 1 %Nouveaux contrats signés pour une valeur de près de 250 millions de dollars de chiffre d’affaires annualisé, soit une progression de 55 % par rapport au premier trimestre 2023Prévisions commerciales à 12 mois de l’ordre de 2,2 milliards de dollarsAcquisition finalisée de Wincanton le 29 avril 2024 GREENWICH, État du Connecticut, 09 mai 2024 (GLOBE NEWSWIRE) -- (NYSE : GXO) publie ce jour ses...

Moody's Ratings affirms CSCECL's and CSCECI's ratings; outlook stable ...

穆迪投资者服务公司 11. 2. 穆迪评级维持中国建筑和中建国际的评级;展望稳定 香港,2024年5月9日—中文新闻稿为英文的翻译件。如有出入,以英文稿为准。 穆迪评级 (穆迪) 已维持中国建筑股份有限公司 (中国建筑)  A2的发行人评级和baa2的基础信用评估 (BCA)。此外,穆迪还维持下列评级:CSCEC Finance (Cayman) II Limited发行、中国建筑提供无条件及不可撤销担保的债券A2的高级无抵押债务评级中建国际建设有限公司 (中建国际) A3的发行人评级与此同时,穆迪维持上述评级的稳定展望。穆迪副总裁/高级分析师刘玉婷表示:“维持中国建筑的评级反映了公司作为中国...

Jonathan Chaplin
  • Jonathan Chaplin

SATS: model update

This note covers updates to the model following consolidated EchoStar results. We increased service revenue and EBITDA. Our free cash flow is up very modestly. The company has five to seven months to raise capital. We updated our valuation to $95 / share. We will have another update out once we get the Dish, DBS & Hughes 10-Qs.

 PRESS RELEASE

CompoSecure Announces Pricing of Secondary Offering of Shares of Class...

CompoSecure Announces Pricing of Secondary Offering of Shares of Class A Common Stock by Selling Shareholders SOMERSET, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- (“CompoSecure”) (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the pricing of a secondary offering of 7,000,000 shares of its Class A common stock, par value $0.0001 per share, by certain shareholders of the Company (the “Selling Shareholders”) at a price to the public of $6.50 per share for total gross proceeds of $45,500,000 million (the “Offering”). In connection with the...

 PRESS RELEASE

Outlook Therapeutics® to Report Financial Results for Second Quarter F...

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast ISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it will report its financial results for second quarter fiscal year 2024 on Thursday, May 16, 2024. Outlook Therapeutics management will host its inaugur...

Trelleborg AB: 1 director

A director at Trelleborg AB bought 1,600 shares at 36.084USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Bank Ozk: 1 director

A director at Bank Ozk sold 5,875 shares at 47.950USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch